Previous close | 86.61 |
Open | 86.46 |
Bid | 86.89 x 800 |
Ask | 86.76 x 1000 |
Day's range | 86.46 - 86.89 |
52-week range | 77.04 - 98.52 |
Volume | 1,695,049 |
Avg. volume | 2,006,583 |
Market cap | 195.872B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 24.64 |
EPS (TTM) | 3.52 |
Earnings date | N/A |
Forward dividend & yield | 3.20 (3.69%) |
Ex-dividend date | 04 Mar 2021 |
1y target est | 104.67 |
According to Wall Street, the following five megacap stocks -- i.e., publicly traded companies with a market cap of at least $200 billion -- offer upside over the next 12 months ranging from 19% to as much as 32%. Is anyone really all that surprised that e-commerce giant Amazon (NASDAQ: AMZN) is on this list?
Novartis (NVS) enters a three-year collaboration with Artios to strengthen its radiogland therapies pipeline.
No surprise then that neighbours Roche and Novartis — both run out of Basel, Switzerland — want to occupy the same ground. For years, differing strategies kept the two pharmaceutical companies apart. Roche was a “pure play” pharma company while Novartis was diversified.